Telomir Pharmaceuticals raises $2.9M via block sale of 1.55M shares at $1.87/share

Telomir Pharmaceuticals, Inc.

Sold 1,550,000 shares of common stock to institutional investors at $1.87 average price.
Gross proceeds of approximately $2.9 million, before fees and expenses.
Price represented a premium to the prior day's closing price.
Transaction executed via the StockBlock platform through Rodman & Renshaw; no warrants issued.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.